Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis
Background. Digital health technologies (DHTs) have shown potential to improve health outcomes through improved medication adherence in different disease states. Cystic fibrosis (CF) requires care coordination across pharmacies, patients, and providers. DHTs can potentially support patients, provide...
Main Authors: | Alexandre H. Watanabe, Connor Willis, Russell Ragsdale, Joseph Biskupiak, Karlene Moore, Diana Brixner, David Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2023/5082499 |
Similar Items
-
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods
by: Joseph Biskupiak, et al.
Published: (2024-03-01) -
Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis
by: John Edmund Moore, et al.
Published: (2022-01-01) -
Home Spirometry in Children with Cystic Fibrosis
by: Ariel Berlinski, et al.
Published: (2023-02-01) -
What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?
by: Gwyneth Davies, et al.
Published: (2020-09-01) -
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis
by: Alessia Finotti, et al.
Published: (2025-01-01)